Skip to main content
. 2023 Dec 27;10(1):e23923. doi: 10.1016/j.heliyon.2023.e23923

Table 2.

General clinical data non-remission group remission group and non-remission group description.

Group remission group non-remission group P
Quantity 67(65.69 %) 35(34.31 %)
Age (mean ± standard deviation) 62.46 ± 8.47 61.63 ± 8.57 0.2961
Gender 60(89.55 %) 0.0062
Man 7(10.45 %) 23(65.71 %)
Woman 12(34.29 %)
Smoke 48(71.64 %) 0.0515
Yes 19(28.36 %) 18(51.43 %)
No 17(48.57 %)
History of chronic lung disease 8(11.94 %) >0.9999
Yes 59(88.06 %) 4(11.43 %)
No 31(88.57 %)
Pathological pattern 39(58.21 %) 0.0971
squamous carcinoma 28(41.79 %) 14(40.00 %)
Adenocarcinoma and others 21(60.00 %)
Staging 2(2.99 %) 0.6590
II 44(65.67 %) 2(5.71 %)
III 21(31.34 %) 20(57.14 %)
IV 13(37.14 %)